Table 2. Changes in blood pressure, lipid profile and hemoglobin A1c levels within both groups before and after study.
| Intervention group (n = 106) | Control group (n = 102) | p value* | |
| SBPat baseline (mmHg) | 128.5 ± 17.6 | 128.2 ± 17.1 | 0.856 |
| DBP at baseline (mmHg) | 72.8 ± 10.7 | 71.8 ± 9.8 | 0.472 |
| SBP at 1 year | 131.9 ± 17.6 | 133.0 ± 18.1 | 0.496 |
| DBP at 1 year | 73.1 ± 11.5 | 73 ± 11.7 | 0.783 |
| SBP at 2 years | 133 ± 18.1 | 133.3 ± 20.9 | 0.275 |
| DBP at 2 years | 72.3 ± 10.7 | 73.1 ± 11.7 | 0.644 |
| Lipid profile | |||
| LDL-C at baseline (mg/dL) | 112.2 ± 35.4 | 113.3 ± 34.5 | 0.507 |
| LDL-C after 1 year | 77.71 ± 24.3 | 88.8 ± 34.5 | 0.023* |
| LDL-C after 2 years | 79.1, 23.5 | 84.1, 28.3 | 0.043* |
| HDL-C at baseline (mg/dL) | 43.4 ± 11.6 | 46.5 ± 21.4 | 0.451 |
| HDL-C after 1 year | 49.4 ± 12.4 | 49.3 ± 11.3 | 0.005* |
| HDL-C after 2 years | 50.6, 14.7 | 49.3, 12.7 | 0.001* |
| TC at baseline (mg/dL) | 176.3 ± 43.3 | 178.2 ± 38.6 | 0.426 |
| TC after 1 year | 148.6 ± 31.3 | 159.5 ± 43.9 | 0.021* |
| TC after 2 years | 151.4, 30.1 | 154.5, 34.9 | 0.420 |
| HbA1c at baseline | 6.58 ± 1.48 | 6.66 ± 1.46 | 0.695 |
| HbA1c after 1 year | 6.32 ± 0.91 | 6.57 ± 1.23 | 0.028* |
| HbA1c after 2 years | 6.373 ± 0.94 | 6.77 ± 1.33 | 0.003* |
* Analysis of cluster structure variability (ANOCVA).
BP, blood pressure; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein-cholesterol; SBP, systolic blood pressure; TC, total cholesterol.
1 year: measurements at 1 year after discharge; 2 years: measurements at 2 years after discharge.
# There were 78 patients and 74 patients with hypertension in control group and intervention group respectively. There were 35 patients and 36 patients with diabetes mellitus in control group and intervention group respectively. There were 81 patients and 75 patients with hyperlipidemia in control group and intervention group respectively.